Lipodystrophy-Associated Metabolic Syndrome in Patients With HIV - Infectious Disease Advisor

Researchers assessed the effect of lipodystrophy-associated metabolic syndrome on oxidative stress and inflammatory processes in patients with HIV infection.

In patients with HIV infection and metabolic syndrome (MS), those with lipodystrophy (LD) receiving protease inhibitor (PI)-based antiretroviral therapy (ART) regimens for at least 6 months were more… [+3358 chars]

full article...